Belatacept (
NULOJIX®) is a prescription medication approved to prevent transplant rejection in people receiving a kidney transplant. It is always used in combination with other anti-rejection medications. Belatacept is only approved for use in people who are immune to a virus known as the Epstein-Barr virus (EBV).
Just like any medicine, belatacept may cause side effects.
However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well.
If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of belatacept include but are not limited to:
(Click Belatacept Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)